QuidelOrtho director awarded 2,156 common shares
QuidelOrtho Corp director Kenneth F. Buechler increased his direct stake through equity compensation rather than market buying.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
QuidelOrtho Corp director Kenneth F. Buechler increased his direct stake through equity compensation rather than market buying. On June 6, 2026, he acquired 497 and 1,659 shares of Common Stock at $0.00 per share as grants linked to restricted stock units. These 2,156 shares came from the release and conversion of previously reported restricted stock units under QuidelOrtho's deferred compensation program for participating non-employee directors. Following the transactions, Buechler directly owns 110,906 common shares.
Insider Trade Summary
2,156 shares exercised/converted
Exercise
4 txns
Insider
BUECHLER KENNETH F
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units (Converted) | 1,659 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units (Premium) | 497 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 1,659 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 497 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units (Converted) — 0 contracts (Direct);
Restricted Stock Units (Premium) — 0 contracts (Direct);
Common Stock — 110,906 shares (Direct)
Footnotes (3)
- F1. Reflects release of restricted stock units that were previously reported on a Form 4.
- F2. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
- F3. Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.
Key Figures
RSU-derived share grant 1: 497 shares
RSU-derived share grant 2: 1,659 shares
Total RSU exercises: 2,156 shares
+3 more
6 metrics
RSU-derived share grant 1
497 shares
Common Stock granted at $0.00 per share on June 6, 2026
RSU-derived share grant 2
1,659 shares
Common Stock granted at $0.00 per share on June 6, 2026
Total RSU exercises
2,156 shares
Exercise or conversion of derivative securities (RSUs)
Post-transaction holdings
110,906 shares
Common Stock directly owned after transactions
Transaction price
$0.00 per share
Price for the common stock grants on June 6, 2026
Exercise transactions
2 derivative exercises
RSUs converted into common stock
Key Terms
Restricted Stock Units, deferred compensation program, non-employee directors, derivative security
4 terms
Restricted Stock Units financial
"Reflects release of restricted stock units that were previously reported on a Form 4."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
deferred compensation program financial
"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors"
non-employee directors financial
"program applicable to participating non-employee directors and occurred according to the elected deferred schedule."
Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did QuidelOrtho (QDEL) director Kenneth F. Buechler report on this Form 4?
Kenneth F. Buechler reported acquiring additional QuidelOrtho common shares through equity compensation, not open-market purchases. The filing shows restricted stock units converting into common stock and being released under the company’s deferred compensation program for non-employee directors.
Were Kenneth F. Buechler’s QuidelOrtho (QDEL) transactions open-market buys or compensation awards?
The transactions were compensation-related awards, not open-market purchases. The Form 4 labels them as grants and exercises of restricted stock units, with a transaction price of $0.00 per share, tied to QuidelOrtho’s deferred compensation program for non-employee directors.
What do the restricted stock unit (RSU) exercises mean for QuidelOrtho (QDEL) director compensation?
The RSU exercises show part of Buechler’s compensation is paid in equity rather than cash. Each restricted stock unit converted into one common share, and the release followed the schedule elected under QuidelOrtho’s deferred compensation program for participating non-employee directors.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates